Edesa Biotech, Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-05-19
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
News release - English.pdf
Results 2026-05-14
Interim MD&A - English.pdf
Results 2026-05-14
Interim financial statements/report – English.pdf
Results 2026-05-14
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
News release - English.pdf
News 2026-03-31
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
News release - English.pdf
News 2026-03-26
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
News release - English.pdf
Results 2026-02-24
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
News release - English.pdf
Results 2026-02-13 Financials
Interim MD&A - English.pdf
Results 2026-02-13 Financials
Interim financial statements/report – English.pdf
Results 2026-02-13
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
News release - English.pdf
News 2025-12-17
Offering material - English.pdf
News 2025-12-17
Offering material - English.pdf
Results 2025-12-13 Financials
Annual report on form 10-K - English.pdf
Results 2025-12-13 Financials
Annual MD&A - English.pdf
Results 2025-12-13 Financials
Audited annual financial statements – English.pdf
Results 2025-12-12
Edesa Biotech Reports Fiscal Year 2025 Results
News release - English.pdf
News 2025-10-31
News release - English.pdf
News 2025-10-28
News release - English.pdf
News 2025-09-24
Offering material - English.pdf
News 2025-09-24
Offering material - English.pdf
News 2025-08-08
News release - English.pdf
Results 2025-08-08 Financials
Interim MD&A - English.pdf
Results 2025-08-08 Financials
Interim financial statements/report – English.pdf
News 2025-07-25
Offering material - English.pdf
Ownership 2025-02-14
3 insiders · +$1.1M net
Insider trading – 2025-02-14
3 insiders · +$1.1M net
Ownership 2024-11-01
Nijhawan, Pardeep bought +$1.5M
Insider trading – 2024-11-01
1 insider · +$1.5M net